跳至主要内容
临床试验/NCT02050126
NCT02050126已完成不适用

Caesarean Scar Revision With the UltraPulse

Lumenis Be Ltd.2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Scar Evaluation

研究概览

简要总结

Ten (10) adult female subjects that had a caesarean surgery performed.Study will be conducted in 1 site.

Each subject will receive three treatments on one area that was randomly chosen. The other area will be left untreated and will serve as a control.

The objective is to Evaluate the clinical impact of UltraPulse fractional carbon dioxide laser treatment on the appearance of a Caesarean Scar (CS) as compared to a similar untreated scar side.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Females in good general health older than 22 years of age and younger than 55 years of age.
  • Presenting with a caesarean scar mature and stable caesarean scar (at least 1 year post procedure).
  • At least six months following termination of breast feeding.
  • Willing to give and sign an informed consent form and a photographic release form.
  • Willing to comply with study dosing and complete the entire course of the study .
  • Performed negative pregnancy test.

排除标准

  • Active bacterial, fungal, or viral infection in the treatment area.
  • Active cold sores, or herpes in the treatment area.
  • Recent excessive exposure to sunlight or artificial UV light (e.g.: use of tanning beds/booths and/or sunbathing) or expectations of tanning during the time of the study .
  • History of or the presence of any skin condition/disease that might interfere with the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema, psoriasis).
  • Treatment with a systemic retinoid within the past year (e.g., Accutane®, Roche Dermatologics).
  • History or presenting with a keloid scar.
  • Any current or recent treatment for cancer.
  • Any uncontrolled systemic disease. A potential subject in whom therapy for a systemic disease is not yet stabilized will not be considered for entry into the study.
  • Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
  • Previous laser treatments on the same scar at least 0.5 year prior to this evaluation.
  • Subject planning any other cosmetic procedure to the study area during the study period, other than the treatments that will be performed by the investigator .
  • Any other condition that may exclude patient for treatment per physician discretion.
  • Female subject who is pregnant, nursing an infant .

结局指标

主要结局

Scar Evaluation

时间窗: 3 month following the 3rd treatment.

VSS , POSAS, Appearance assessment-Evaluation of the scar by blinded investigator.

次要结局

  • Scar Evaluation.(At base line , at the 3rd treatment and at the 1, 3 and 6 months follow-up)
  • POSAS assessment(At base line , at the 3rd treatment and at the 1, 3 and 6 months follow-up)
  • Scar Thickness and Uniformity(At base line, at the 3rd treatment and at the 1, 3 and 6 months follow-up)
  • Scar color(At base line, at the 3rd treatment and at the 1, 3 and 6 months follow-up.)
  • Histochemical Changes in scar tissue(Immediately before the 2nd, and 3rd treatment)
  • Subject's satisfaction(At the 3rd treatment and at the 1, 3 and 6 month follow-up)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验